GDP implementation for medicine distribution in Montenegro
GDP implementation for medicine distribution in Montenegro: SOPs, storage and transport controls, deviations, CAPA and preparation for CInMED inspection.
Request an initial assessment
GDP implementation for medicine distribution in Montenegro: SOPs, storage and transport controls, deviations, CAPA and preparation for CInMED inspection.
Request an initial assessment
ConsultHQ provides GDP implementation and improvement support for medicine distribution in Montenegro. We connect the quality system, SOPs, storage, transport, deviations and CAPA with the actual flow of medicines through your organisation.
We prepare the system for regulatory inspection. CInMED issues the GDP certificate after verifying the required conditions; consulting does not constitute certification.
The result of the project should be a system that the wholesaler can continue to use and maintain.
Depending on the scope of the engagement, the client receives:
This is significantly different from buying a ready-made GDP package.
The documentation is created from the process that the wholesaler really has.
The scope of engagement depends on whether the wholesaler is just establishing the system, is already operating or is preparing for a new GDP check.
Implementation may include:
We do not introduce the same package to every wholesaler.
We adapt the system to the actual volume of traffic, space, temperature regimes and the way transport is organized.
A review should allow a shipment to be traced through the system. These examples illustrate the connections we examine according to the organisation’s activities.
A logger, SOP or contract alone does not demonstrate control. We check whether data are available, responsibilities are clear and procedures are applied. Decisions on medicine status remain with authorised personnel within the relevant regulatory framework.
Within the agreed scope, we review contractual responsibilities, transport requirements, available evidence and deviation reporting. A contract does not replace verification that the service is appropriately controlled.
Sites and activities, temperature regimes, transport scope, existing documentation, qualification evidence and open findings. Consulting, technical qualification or measurement activities and regulatory fees are clarified separately.
Describe your organisation’s role, sites, activities, temperature regimes and transport arrangements. Include the current authorisation status, available SOP documentation and any open inspection findings.
Explore support for pharmaceutical wholesalers and GDP transport, or request a GDP system assessment. Official requirements and forms are available from CInMED.
The European guidelines on good distribution practice (2013/C 343/01) elaborate the requirements for the wholesale of medicinal products under Directive 2001/83/EC. In Montenegro, their application should be connected with valid domestic regulations and CInMED guidelines.
The wholesale circulation of medicines in Montenegro includes the procurement, storage, supply or export of medicines, except for the dispensing of medicines to the general public.
CInMED states that a legal or natural person who carries out the wholesale distribution of medicines must act in accordance with the Good Practice Guidelines in the distribution of medicines for human use.
CInMED issues a wholesale license for human medicines.
The Institute also issues a GDP certificate after verifying the fulfillment of the prescribed conditions. The certificate is issued before the start of wholesale trade and can be valid for up to five years from the inspection.
This distinguishes GDP from a voluntary system that a company introduces only because of a commercial requirement.
For companies engaged in wholesale distribution, the system must reflect the specific GDP requirements for pharmaceutical wholesalers.
The current Law on Medicines (Official Gazette of Montenegro Nos. 14/26 and 94/26) includes the July 2026 amendments. CInMED states that the new framework applies to procedures initiated from 17 February 2026.
During the announcement, CInMED specifically pointed out new obligations, standards harmonized with European Union regulations and the need for timely business adjustments.
During 2026, the Institute additionally updated the GDP guidelines, standardized forms, procedures for the GDP certificate and documentation for wholesale permits.
That's why the existing GDP documentation should not be automatically considered current just because it was previously checked.
Changes in regulatory requirements should be systematically monitored and linked to internal procedures.
Existing wholesalers usually already have much of the necessary system in place.
The problem may be in the details that carry significant regulatory risk.
Temperature monitoring exists, but deviations have not been systematically investigated. CAPA documentation exists, but the measures are closed without verification of effectiveness.
Or the SOP procedures simply no longer correspond to the actual way of working.
Through gap analysis, we review documentation and practice together.
The result is an overview of deviations and priority activities that need to be resolved before the regulatory review.
That way, the company doesn't waste time rewriting parts of the system that already work.
GDP is not the job of the QA function alone.
Procurement affects supplier qualification. The warehouse controls receipt, status and storage conditions.
Logistics affects transportation.
The responsible person must have sufficient information and authority to make a decision when product quality may be compromised.
That's why we clearly link functions and responsibilities during implementation.
The goal is for everyone to know where their GDP responsibility begins and ends.
This reduces situations where an important event is left between two departments.
A generic SOP can look professional without much connection to a real warehouse.
Such documentation becomes a problem as soon as the inspection compares the written procedure with practice.
First, that's why we monitor the actual course of the drug.
From suppliers and receiving, through warehouse and product status, to issuing, transportation and final delivery.
Based on that, we edit the procedures and records.
Documentation should enable proof of control.
Not to create a parallel mode of operation that employees use only when they expect a check.
One of the most important GDP areas is the preservation of the necessary storage conditions.
But a temperature logger by itself does not make the system compliant.
It is necessary to connect the qualification of the space, temperature mapping, monitoring, calibration, alarming and handling of deviations.
During the GDP review, we check exactly this connection.
We do not give employees generic instructions on where to place each sensor.
We check whether the existing qualification and monitoring provide sufficient evidence that the company controls the conditions in which it stores medicines.
If there is a gap, we define what needs to be supplemented or reassessed.
GDP liability does not end when the shipment leaves the warehouse.
Transport and storage of medicinal products require particular attention because temperature control, product protection and oversight of external providers remain part of the GDP system.
Therefore, as part of the project, we review how the wholesaler defines transport requirements, chooses the appropriate solution and controls external transporters.
Temperature-sensitive products require special attention.
Monitoring, qualification evidence, packaging, vehicle and way of reacting to deviation are evaluated there.
When the transport is performed by a third party, we also check the way GDP responsibilities are defined and documented.
Outsourcing services should not create a gap in the quality system.
The wholesaler must have control over who he buys from and to whom he distributes medicines.
That is why the qualification of business partners belongs to the GDP system.
During implementation, we review the existing approval model and re-evaluate suppliers and customers.
The goal is not just to make another table.
It is necessary that the organization can demonstrate that the partner has the appropriate status and that the relevant changes are monitored.
This reduces the risk of product entering from an uncontrolled source or distribution outside the appropriate chain.
GDP inspection does not expect an organization without any problems.
Much more important is how the organization reacts when a problem arises.
Temperature deviation, equipment problem, incorrect status of goods or repeated complaint should initiate a controlled procedure.
During the project, we therefore review how the company:
On June 12, 2026, CInMED published a special instruction for the submission of the CAPA plan after the GDP inspection and the harmonized form of the CAPA plan.
That is why CAPA is not a minor administrative issue.
It is directly related to the regulatory procedure after the inspection findings.
When the product leaves the warehouse, the system must retain enough data for the wholesaler to track it.
This becomes especially important when a complaint, return or withdrawal of a particular batch needs to be processed.
During GDP implementation, we review whether the documentation and information systems provide the necessary traceability.
We also check whether the responsibilities for decision-making are clearly distributed.
We are not creating a theoretical procedure that no one has tested.
The goal is for the organization to be able to quickly access relevant data when an actual event occurs.
A new WMS, a conveyor change or a new cold room may seem like purely operational decisions.
For the GDP system, these can be significant changes.
That's why during implementation we edit the way the company evaluates their impact before full implementation.
The change may require additional qualification, procedure change or employee training.
In this way, the system remains under control even when the business is developing.
The storekeeper and the responsible person do not need the same GDP training.
The employee in the warehouse must clearly understand the status of the product, the storage conditions and the handling of the problems he sees in his daily work.
Procurement needs to understand supplier control.
Logistics should know the requirements relevant to transport.
The responsible person and the QA function need a bigger picture of the system and regulatory requirements.
That's why we connect training with real roles.
Signing on the attendance list is not the end goal.
The employee should know what he is doing when there is a real deviation.
Before a regulatory inspection, it is useful to look at the system through the eyes of an auditor.
Self-inspection should follow actual processes.
We review the documentation, talk to the employees and check whether the practice corresponds to the defined system.
We then turn the findings into concrete corrective actions.
This gives the company room to detect and resolve a serious problem before regulatory scrutiny.
The goal of an internal audit is not to show that everything is perfect.
The goal is to show in time what is still not good enough.
ConsultHQ can help a company build a system, adjust documentation, train employees and prepare for regulatory review.
The GDP certificate is issued by CInMED after checking the fulfillment of the relevant conditions.
We make that difference clear from the beginning of the engagement.
We do not promise a certificate as a result of the consulting service.
We prepare the organization to be able to prove its system before the competent regulatory body.
Our current GDP review uses the Law on Medicines (Official Gazette Nos. 14/26 and 94/26) and CInMED’s Guidelines on Good Distribution Practice for Human Medicines published on 22 July 2026. For inspection findings, CInMED published CAPA-plan instructions and a standard form on 12 June; it published the GDP inspection procedure and standardised GDP documents on 19 August, and updated wholesale-authorisation and GDP-certificate request forms on 15 September. We check the current version directly with CInMED before submission.
The regulatory framework is not static.
On July 22, 2026, CInMED published Guidelines for Good Practice in the Distribution of Medicines for Human Use, and during August standardized GDP documents and reports.
On the page for the sale of wholesale drugs, the instructions for the GDP certificate, the CAPA instruction and updated forms for wholesale licenses and the GDP certificate are currently available.
That is why external regulatory documents should be controlled within the GDP system.
An old locally saved version of a form or instruction should not automatically remain in use.
A GDP system can have many procedures and still be weak.
This happens when quality is driven by documentation, while operational teams do not perceive the system as part of their work.
Such a model often becomes visible during inspection.
The employee does not know the procedure. The record is formal. The CAPA measure exists but is not actually implemented.
That's why we build the implementation through operational processes.
GDP should function on a normal working day.
Then the preparation for the inspection is much simpler.
Active wholesaling usually doesn't need an entirely new system.
Perhaps the CAPA should be edited, the SOP documentation should be updated, or monitoring and deviations should be better linked.
The new wholesale has a different task.
With it, GDP should be developed in parallel with space, equipment, personnel and regulatory requirements for starting work.
Through an initial assessment, ConsultHQ determines where the company is currently located and which activities have the highest priority.
After that, you get a clear plan of what to keep, what to correct and what to finish before the next CInMED GDP check.
An initial assessment helps us define scope and next steps based on your actual business.
Request an initial assessment